S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in

Akumin Stock Forecast, Price & News

+0.11 (+2.47 %)
(As of 03/5/2021 03:59 PM ET)
Today's Range
Now: C$4.57
50-Day Range
MA: C$4.16
52-Week Range
Now: C$4.57
Volume43,533 shs
Average Volume59,542 shs
Market CapitalizationC$320.71 million
P/E RatioN/A
Dividend YieldN/A
Akumin Inc. provides outpatient diagnostic imaging services in the United States. As of December 31, 2019, the company operated 129 imaging centers located in Florida, Pennsylvania, Delaware, Georgia, Texas, Illinois, and Kansas. Its centers offer physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders, and reduce unnecessary invasive procedures. The company provides a range of medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, radiology, and other diagnostic or interventional radiology procedures; and online medical bill payment services. Akumin Inc. is headquartered in Toronto, Canada.


Akumin Enters into Settlement Agreement
February 1, 2021 |  finance.yahoo.com
Is Akumin Inc. (AKU) A Good Stock To Buy?
November 26, 2020 |  finance.yahoo.com
Akumin Inc. (AKU.TO)
November 12, 2020 |  finance.yahoo.com
Akumin Inc. Announces Third Quarter 2020 Financial Results
November 12, 2020 |  finance.yahoo.com
Akumin Inc. Common Shares (AKU)
September 7, 2020 |  nasdaq.com
Akumin to Commence Trading on NASDAQ
September 2, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Diagnostics & Research
Year FoundedN/A



Sales & Book Value

Annual SalesC$269.04 million
Cash FlowC$0.38 per share
Book ValueC$1.95 per share



Market CapC$320.71 million
Next Earnings Date3/30/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

0.73 out of 5 stars

Analyst Opinion: 1.3Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
+0.11 (+2.47 %)
(As of 03/5/2021 03:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AKU News and Ratings via Email

Sign-up to receive the latest news and ratings for AKU and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Akumin (TSE:AKU) Frequently Asked Questions

Is Akumin a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akumin in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Akumin stock.
View analyst ratings for Akumin
or view top-rated stocks.

What stocks does MarketBeat like better than Akumin?

Wall Street analysts have given Akumin a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Akumin wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Akumin's next earnings date?

Akumin is scheduled to release its next quarterly earnings announcement on Tuesday, March 30th 2021.
View our earnings forecast for Akumin

How has Akumin's stock price been impacted by Coronavirus (COVID-19)?

Akumin's stock was trading at C$4.01 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, AKU shares have increased by 14.0% and is now trading at C$4.57.
View which stocks have been most impacted by COVID-19

What price target have analysts set for AKU?

2 equities research analysts have issued 12 month price objectives for Akumin's stock. Their forecasts range from C$3.25 to C$5.25. On average, they anticipate Akumin's share price to reach C$4.25 in the next twelve months. This suggests that the stock has a possible downside of 7.0%.
View analysts' price targets for Akumin
or view top-rated stocks among Wall Street analysts.

Who are Akumin's key executives?

Akumin's management team includes the following people:
  • Mr. Riadh Zine-El-Abidine, Pres, CEO & Director (Age 49, Pay $1.26M)
  • Mr. Mohammad Saleem, CFO & Corp. Sec.
  • Mr. Rohit Navani, Exec. VP & COO
  • Mr. Matthew Cameron, Sr. VP & Gen. Counsel
  • Mr. Christopher Fitzgerald, Chief Revenue Officer
  • Darren Speed, Chief Compliance Officer
  • Karen Moore, VP of HR
  • Ms. Laura Kassa, Sr. VP
  • Adam Fabian, Corp. Controller
  • Mr. Kevin G. Johnson, CEO & Pres of Advanced Diagnostic Group, LLC

Who are some of Akumin's key competitors?

What other stocks do shareholders of Akumin own?

What is Akumin's stock symbol?

Akumin trades on the Toronto Stock Exchange (TSX) under the ticker symbol "AKU."

How do I buy shares of Akumin?

Shares of AKU and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Akumin's stock price today?

One share of AKU stock can currently be purchased for approximately C$4.57.

How much money does Akumin make?

Akumin has a market capitalization of C$320.71 million and generates C$269.04 million in revenue each year.

How many employees does Akumin have?

Akumin employs 1,737 workers across the globe.

What is Akumin's official website?

The official website for Akumin is www.akumin.com.

How can I contact Akumin?

The company can be reached via phone at 416-613-1391.

This page was last updated on 3/8/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.